Image

Global Intractable Pneumothorax Treatment Market - Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Intractable Pneumothorax Treatment Market - Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Intractable Pneumothorax Treatment Market - Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 32,960.00 USD Million
Diagram Market Size (Forecast Year) USD 54,140.25 USD Million
Diagram CAGR %

Major Markets Players

  • Abbott
  • Medtronic
  • Angiotech
  • BetaGlue
  • Teleflex orporated

Global Intractable Pneumothorax Treatment Market, By Types (Traumatic Pneumothorax and Nontraumatic Pneumothorax), Drugs Class (Antibiotics, Benzodiazepines, Opiate Anesthetics and Others), Diagnosis (Chest Radiography, CT Scan, Thoracic Ultrasound and Others), Treatment (Medications, Supportive Care and Surgery), Route of Administration (Oral, Inhalation and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics and Others) - Industry Trends and Forecast to 2030.

Intractable Pneumothorax Treatment Market

Intractable Pneumothorax Treatment Market Analysis and Size

Intractable pneumothorax is a medical condition in which air becomes trapped in the pleural space (the area between the lung and the chest wall) and cannot be easily evacuated. Treatment for intractable pneumothorax may involve various approaches, including medical management, minimally invasive procedures, or surgery. An increase in the incidence and prevalence of intractable pneumothorax can drive market growth. Factors such as smoking, lung diseases, and trauma can contribute to the occurrence of pneumothorax.

Data Bridge Market Research analyses that the global intractable pneumothorax treatment market  which was USD 32,960.00 million in 2022, would rocket up to USD 54,140.25 million by 2030, and is expected to undergo a CAGR of 6.7% during the forecast period. This indicates the market value. “Traumatic Pneumothorax” dominates the type segment of the global intractable pneumothorax treatment market owing to the increasing investment in healthcare. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Intractable Pneumothorax Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Types (Traumatic Pneumothorax and Nontraumatic Pneumothorax), Drugs Class (Antibiotics, Benzodiazepines, Opiate Anesthetics and Others), Diagnosis (Chest Radiography, CT Scan, Thoracic Ultrasound and Others), Treatment (Medications, Supportive Care and Surgery), Route of Administration (Oral, Inhalation and Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics and Others)

Countries Covered

U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

Market Players Covered

Abbott (U.S.), Medtronic (Ireland), Angiotech (Canada), BetaGlue (Canada), Teleflex Incorporated (U.S.), Vygon (France), Utah Medical Products, Inc (U.S.), Smiths Group plc (U.K.), ATMOS MedizinTechnik GmbH & Co. KG (Germany), Sinapi Biomedical (Turkey), Nobelpharma Co., Ltd (Japan), Zebra Medical Vision, Inc (Israel), Thermo Fisher Scientific (U.S.), AbbVie Inc (U.S.), Pfizer Inc (U.S.), Bayer AG (Germany), Novartis AG (Switzerland), Bristol-Myers Squibb Company (U.S.), bioMérieux SA (France), and Bio-Rad Laboratories, Inc (U.S.)

Market Opportunities

  • Growing healthcare infrastructure
  • Strategic initiatives by key market players
  • Rising demand for oncology therapeutics

Market Definition

Pneumothorax is a medical condition characterized by the presence of air in the pleural space (the space between the lung and the chest wall), which can lead to lung collapse. Intractable pneumothorax refers to cases of pneumothorax that are difficult to manage or treat using standard interventions, such as chest tube placement or aspiration. These cases may require more specialized and advanced treatment options. This encompasses a wide range of medical interventions and approaches to manage and resolve intractable pneumothorax. Treatment options may include surgical procedures, minimally invasive techniques, medical therapies, and supportive care measures designed to address the underlying causes and alleviate the condition.

Global Intractable Pneumothorax Treatment Market Dynamics

Drivers

  • Increasing Incidence of Pneumothorax

The rising incidence of pneumothorax, both spontaneous and traumatic, contributes to the demand for intractable pneumothorax treatments. Factors such as smoking, chronic lung diseases, and accidents can increase the risk of pneumothorax.

  • Advancements in Medical Technology

Continuous advancements in medical technology have led to the development of more effective and less invasive treatment options for intractable pneumothorax. Minimally invasive techniques and improved surgical tools have enhanced patient outcomes and recovery.

Opportunity

  • Patient Education and Awareness

Increasing patient and healthcare provider awareness about the management and treatment of pneumothorax can lead to early diagnosis and timely treatment, which can positively impact the market. Furthermore, the rising collaboration, merger, and acquisition among the market players will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Additionally, rising number of market players will further expand the market's growth rate in the future. 

Restraint/Challenge

  • Limited Availability of Specialized Healthcare Facilities

Access to specialized healthcare facilities equipped to handle intractable pneumothorax cases may be limited in some areas. Patients may need to travel long distances to receive appropriate care. Advanced treatments for intractable pneumothorax, such as surgical procedures and minimally invasive interventions, can be expensive. High treatment costs may limit access to these therapies, especially in regions with limited healthcare resources.

This global intractable pneumothorax treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global intractable pneumothorax treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In September 2019, The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to GE Healthcare’s artificial intelligence (AI) algorithms, Critical Care Suite, to identify pneumothorax, a type of collapsed lung. Therefore, it has increased the demand for the treatment of pneumothorax.

Global Intractable Pneumothorax Treatment Market Scope

The global intractable pneumothorax treatment market is segmented on the basis of type, drugs class, diagnosis, treatment, route of administration, distribution channel, and end-users. The growth amongst these segments will help you analyse meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Traumatic Pneumothorax
  • Nontraumatic Pneumothorax

Drugs Class

  • Antibiotics
  • Benzodiazepines
  • Opiate Anesthetics
  • Others

Diagnosis

  • Chest Radiography
  • CT Scan
  • Thoracic Ultrasound
  • Others

Treatment

  • Medications
  • Supportive Care
  • Surgery

Route of Administration

  • Oral
  • Inhalation
  • Parenteral

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Global Intractable Pneumothorax Treatment Market Regional Analysis/Insights

The global intractable pneumothorax treatment market is analyzed, and market size insights and trends are provided by type, drugs class, diagnosis, treatment, route of administration, distribution channel, and end-users as referenced above.

The countries covered in the global intractable pneumothorax treatment market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa

North America dominates the global intractable pneumothorax treatment market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising healthcare expenditure. In addition, favourable health remuneration policies, rise in chronic wounds, and a growing elderly population will further propel the market's growth rate in this region.

Asia-Pacific is expected to be the fastest-growing region during the forecast period of 2023 to 2030 due to increase in the number of insurance payers in this region. Also, the development of private healthcare sector and rising awareness among the people will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The intractable pneumothorax treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for intractable pneumothorax treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the intractable pneumothorax treatment market. The data is available for historic period 2015 to 2020.

Competitive Landscape and Intractable Pneumothorax Treatment Market Share Analysis

The intractable pneumothorax treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to intractable pneumothorax treatment market.

Some of the major players operating in the intractable pneumothorax treatment market are:

  • Abbott (U.S.)
  • Medtronic (Ireland)
  • Angiotech (Canada)
  • BetaGlue (Canada)
  • Teleflex Incorporated (U.S.)
  • Vygon (France)
  • Utah Medical Products, Inc (U.S.)
  • Smiths Group plc (U.K.)
  • ATMOS MedizinTechnik GmbH & Co. KG (Germany)
  • Sinapi Biomedical (Turkey)
  • Nobelpharma Co., Ltd (Japan)
  • Zebra Medical Vision, Inc (Israel)
  • Thermo Fisher Scientific (U.S.)
  • AbbVie Inc (U.S.)
  • Pfizer Inc (U.S.)
  • Bayer AG (Germany)
  • Novartis AG (Switzerland)
  • Bristol-Myers Squibb Company (U.S.)
  • bioMérieux SA (France)
  • Bio-Rad Laboratories, Inc (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Intractable Pneumothorax Treatment Market will be worth USD 54,140.25 million by 2030.
The Intractable Pneumothorax Treatment Market growth rate is 6.7% during the forecast period.
Advancements in Medical Technology & Increasing Incidence of Pneumothorax are the growth drivers of the Intractable Pneumothorax Treatment Market.
The type, drugs class, diagnosis, treatment, route of administration, distribution channel, and end-users are the factors on which the Intractable Pneumothorax Treatment Market research is based.
The U.S. Food and Drug Administration (FDA) granted 510(k) clearance to GE Healthcare’s artificial intelligence (AI) algorithms, Critical Care Suite, to identify pneumothorax, a type of collapsed lung is the latest developments in the Intractable Pneumothorax Treatment Market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials